ATRAHealthcareMicro-Cap

Atara Biotherapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Atara Biotherapeutics, Inc. (ATRA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are ATRA insiders buying or selling?

Atara Biotherapeutics, Inc. insiders reported 10 open-market buys ($6.5M) and 186 sells ($31.3M) across 196 Form 4 filings — a net selling position of $24.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 20, 2026)

Total Form 4 filings
196
SEC EDGAR
Insider filers
23
Insider buys (10)
$6.5M
Insider sells (186)
$31.3M

Insider sentiment

Net selling

Net insider flow of $24.8M in net selling. 1 insider buy in the last 90 days.

Recent ATRA insider transactions

DateInsiderRoleTypeSharesPriceValue
May 20, 2026Anhco NguyenPresident and CEOSale5.2K$9.13$47.8K
May 20, 2026Yanina Grant-HuertaChief Accounting OfficerSale2.4K$9.13$22.0K
May 11, 2026Panacea Innovation Ltd10% OwnerSale313.4K$10.10$3.2M
May 11, 2026EcoR1 Capital, LLC10% OwnerPurchase507.4K$9.35$4.7M
Mar 4, 2026Yanina Grant-HuertaChief Accounting OfficerSale2.1K$5.08$10.7K
Mar 4, 2026Anhco NguyenPresident and CEOSale3.0K$5.09$15.2K
Jan 15, 2026Panacea Innovation Ltd10% OwnerSale80.6K$6.07$489.0K
Nov 19, 2025Anhco NguyenPresident and CEOSale2.9K$13.19$38.4K
Nov 19, 2025Yanina Grant-HuertaChief Accounting OfficerSale1.8K$13.19$23.8K
Aug 20, 2025Panacea Innovation Ltd10% OwnerPurchase55.0K$12.19$670.4K
Jul 21, 2025Panacea Innovation Ltd10% OwnerPurchase19.3K$9.64$186.4K
May 20, 2025Yanina Grant-HuertaChief Accounting OfficerSale2.2K$6.76$15.0K
May 20, 2025Anhco NguyenPresident and CEOSale3.3K$6.76$22.2K
Mar 5, 2025Anhco NguyenPresident and CEOSale3.3K$7.00$23.3K
Mar 5, 2025Eric J HyllengrenEVP, CFO and COOSale1.2K$7.00$8.5K
Mar 5, 2025Jill HenrichEVP, Chief Regulatory OfficerSale1.1K$7.00$7.4K
Nov 20, 2024Jill HenrichEVP, Chief Regulatory OfficerSale1.0K$11.20$11.2K
Nov 20, 2024Eric J HyllengrenEVP, CFO and COOSale1.4K$11.20$15.3K
Nov 20, 2024Anhco NguyenPresident and CEOSale1.7K$11.20$18.6K
Aug 20, 2024Pascal TouchonPresident and CEOSale3.0K$6.63$20.1K
Aug 20, 2024Anhco NguyenEVP, Chief Sci. & Tech OfficerSale1.8K$6.63$12.1K
Aug 20, 2024Amar MuruganEVP, Chief Legal OfficerSale1.2K$6.63$7.7K
Aug 20, 2024Eric J HyllengrenEVP, CFOSale1.1K$6.63$7.1K
Aug 20, 2024Jill HenrichEVP, Global Head RA & QualitySale963$6.63$6.4K
May 21, 2024Pascal TouchonPresident and CEOSale81.5K$0.62$50.3K

Showing the 25 most recent of 196 Form 4 filings for Atara Biotherapeutics, Inc..

Most active ATRA insiders

  • Joe Newell34 filings
  • Isaac E. Ciechanover26 filings
  • Pascal Touchon22 filings
  • Utpal Koppikar22 filings
  • Amar Murugan14 filings

Ask anything about ATRA insider activity

Use Trabud's AI agent to query Atara Biotherapeutics, Inc.'s Form 4 history in plain English — "Show me ATRA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ATRA insider trading FAQ

Are Atara Biotherapeutics, Inc. insiders buying or selling?

Across 196 SEC Form 4 filings, Atara Biotherapeutics, Inc. (ATRA) insiders reported 10 open-market purchases totaling $6.5M and 186 sales totaling $31.3M. That is a net selling position of $24.8M.

How many insiders trade ATRA stock?

23 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Atara Biotherapeutics, Inc.. The most recent filing was accepted on May 20, 2026.

Where does Trabud get ATRA insider trading data?

All ATRA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content